• Info
  • Insider Ownership

Insider Trading & Ownership of Goldstein Dov A Md

Summary
The estimated value of insider holdings of Goldstein Dov A Md is at least $433K dollars as of August 19, 2025. Goldstein Dov A Md is the Chief Financial Officer of BioAge Labs, Inc. and owns shares of BioAge Labs, Inc. (BIOA) stock worth about $403K. Goldstein Dov A Md is the Director of Coya Therapeutics, Inc. and owns shares of Coya Therapeutics, Inc. (COYA) stock worth about $30K.
Signature
/s/ David Snyder, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Goldstein Dov A Md files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Goldstein Dov A Md

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BIOA BioAge Labs, Inc. Chief Financial Officer $403K Feb 18, 2025
COYA Coya Therapeutics, Inc. Director $30K Aug 18, 2025
GANX Gain Therapeutics, Inc. Director Jun 24, 2025
NBSE NeuBase Therapeutics, Inc. Director Sep 9, 2022

Insider Transactions Reported by Goldstein Dov A Md:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.